ArticlePloS one2016

Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy.

Xiao Jun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.